{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:35:06Z","timestamp":1783067706369,"version":"3.54.6"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006019","name":"Van Andel Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019736","name":"Farmer Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease is a common neurodegenerative disease related to both genetic and environmental insults. Epidemiological studies have linked\n                    <jats:italic>Helicobacter pylori (H. pylori<\/jats:italic>\n                    ) infection to Parkinson\u2019s disease risk, but the underlying mechanisms of this association remain unclear. In this study, we investigated whether chronic infection with a pathogenic\n                    <jats:italic>H. pylori<\/jats:italic>\n                    strain could induce \u03b1-synuclein aggregation or neurodegeneration, and whether infection clearance mitigates these effects. We also assessed whether\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection exacerbates \u03b1-synuclein pathology and neuron loss when combined with seeding of \u03b1-synuclein pathology. We find that chronic\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection induces a sustained immune response in the gut and plasma that leads to mild brain inflammation and dopaminergic neuron loss, independent of \u03b1-synuclein pathology. These effects are attenuated by eradication of the infection. In mice with \u03b1-synuclein pathology induced by pre-formed fibrils,\n                    <jats:italic>H. pylori<\/jats:italic>\n                    does not further exacerbate the extent of pathology or neuronal death. Together, these results suggest that\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection can lead to neurodegeneration through inflammatory mechanisms independent of \u03b1-synuclein aggregation. Our findings offer mechanistic insights into how pathogens could influence the risk and progression of Parkinson\u2019s disease.\n                  <\/jats:p>","DOI":"10.1186\/s12974-025-03596-z","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:25:25Z","timestamp":1766413525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Helicobacter pylori infection and \u03b1-synuclein pathology drive parallel neurodegenerative pathways in the substantia nigra"],"prefix":"10.1186","volume":"22","author":[{"given":"Alejandro","family":"Soto-Avellaneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Prigent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Meyerdirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Schautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Andrew","family":"Pospisilik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Brundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael X.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"3596_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, et al. Alpha-synuclein in lewy bodies. Nature. 1997;388:839\u201340. https:\/\/doi.org\/10.1038\/42166.","journal-title":"Nature"},{"key":"3596_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Tredici D, K., Braak H. 100 years of lewy pathology. Nat Reviews Neurol. 2013;9:13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2012.242.","journal-title":"Nat Reviews Neurol"},{"key":"3596_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, et al. Identifying prodromal parkinson\u2019s disease: pre-motor disorders in parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc. 2012;27:617\u201326. https:\/\/doi.org\/10.1002\/mds.24996.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"3596_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14802\/jmd.14002","volume":"7","author":"HY Sung","year":"2014","unstructured":"Sung HY, Park JW, Kim JS. The frequency and severity of Gastrointestinal symptoms in patients with early parkinson\u2019s disease. J Mov Disord. 2014;7:7\u201312. https:\/\/doi.org\/10.14802\/jmd.14002.","journal-title":"J Mov Disord"},{"key":"3596_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/0016-5085(84)90079-9","volume":"87","author":"SJ Qualman","year":"1984","unstructured":"Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal lewy bodies associated with ganglion cell loss in achalasia. Similarity to parkinson\u2019s disease. Gastroenterology. 1984;87:848\u201356.","journal-title":"Gastroenterology"},{"key":"3596_CR6","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1212\/wnl.37.7.1253","volume":"37","author":"WJ Kupsky","year":"1987","unstructured":"Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ. Parkinson\u2019s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology. 1987;37:1253\u20135. https:\/\/doi.org\/10.1212\/wnl.37.7.1253.","journal-title":"Neurology"},{"key":"3596_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson\u2019s disease: the presence of lewy bodies in auerbach\u2019s and meissner\u2019s plexuses. Acta Neuropathol. 1988;76:217\u201321. https:\/\/doi.org\/10.1007\/BF00687767.","journal-title":"Acta Neuropathol"},{"key":"3596_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in meissner\u2019s and auerbach\u2019s plexuses in cases staged for parkinson\u2019s disease-related brain pathology. Neurosci Lett. 2006;396:67\u201372. https:\/\/doi.org\/10.1016\/j.neulet.2005.11.012.","journal-title":"Neurosci Lett"},{"issue":"Suppl 3","key":"3596_CR9","doi-asserted-by":"publisher","first-page":"III1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak H, et al. Staging of the intracerebral inclusion body pathology associated with idiopathic parkinson\u2019s disease (preclinical and clinical stages). J Neurol. 2002;249(Suppl 3):III1\u20135.","journal-title":"J Neurol"},{"key":"3596_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, et al. Staging of brain pathology related to sporadic parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"3596_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-018-1943-7","volume":"137","author":"A Prigent","year":"2019","unstructured":"Prigent A, et al. Enteric alpha-synuclein expression is increased in crohn\u2019s disease. Acta Neuropathol. 2019;137:359\u201361. https:\/\/doi.org\/10.1007\/s00401-018-1943-7.","journal-title":"Acta Neuropathol"},{"key":"3596_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mds.25298","volume":"28","author":"A Gold","year":"2013","unstructured":"Gold A, Turkalp ZT, Munoz DG. Enteric alpha-synuclein expression is increased in parkinson\u2019s disease but not alzheimer\u2019s disease. Mov Disorders: Official J Mov Disorder Soc. 2013;28:237\u201340. https:\/\/doi.org\/10.1002\/mds.25298.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"3596_CR13","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2024.0792","volume":"331","author":"CH Gibbons","year":"2024","unstructured":"Gibbons CH, et al. Skin biopsy detection of phosphorylated alpha-Synuclein in patients with synucleinopathies. JAMA. 2024;331:1298\u2013306. https:\/\/doi.org\/10.1001\/jama.2024.0792.","journal-title":"JAMA"},{"key":"3596_CR14","doi-asserted-by":"publisher","first-page":"e1529","DOI":"10.1212\/WNL.0000000000206772","volume":"100","author":"C Gibbons","year":"2023","unstructured":"Gibbons C, et al. Cutaneous alpha-Synuclein signatures in patients with multiple system atrophy and Parkinson disease. Neurology. 2023;100:e1529\u201339. https:\/\/doi.org\/10.1212\/WNL.0000000000206772.","journal-title":"Neurology"},{"key":"3596_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3988\/jcn.2019.15.2.135","volume":"15","author":"JY Kim","year":"2019","unstructured":"Kim JY, Illigens BM, McCormick MP, Wang N, Gibbons CH. Alpha-Synuclein in skin nerve fibers as a biomarker for Alpha-Synucleinopathies. J Clin Neurol. 2019;15:135\u201342. https:\/\/doi.org\/10.3988\/jcn.2019.15.2.135.","journal-title":"J Clin Neurol"},{"key":"3596_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ene.12842","volume":"23","author":"V Provitera","year":"2016","unstructured":"Provitera V, et al. A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol. 2016;23:333\u20138. https:\/\/doi.org\/10.1111\/ene.12842.","journal-title":"Eur J Neurol"},{"key":"3596_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","volume":"68","author":"M Funayama","year":"2023","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N. Molecular genetics of parkinson\u2019s disease: contributions and global trends. J Hum Genet. 2023;68:125\u201330. https:\/\/doi.org\/10.1038\/s10038-022-01058-5.","journal-title":"J Hum Genet"},{"key":"3596_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JPD-212929","volume":"12","author":"S Shen","year":"2022","unstructured":"Shen S, Zhang C, Xu YM, Shi CH. The role of pathogens and Anti-Infective agents in parkinson\u2019s Disease, from etiology to therapeutic implications. J Parkinson\u2019s Disease. 2022;12:27\u201344. https:\/\/doi.org\/10.3233\/JPD-212929.","journal-title":"J Parkinson\u2019s Disease"},{"key":"3596_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/cns.13990","volume":"29","author":"Z Li","year":"2023","unstructured":"Li Z, et al. Gut bacterial profiles in parkinson\u2019s disease: A systematic review. CNS Neurosci Ther. 2023;29:140\u201357. https:\/\/doi.org\/10.1111\/cns.13990.","journal-title":"CNS Neurosci Ther"},{"key":"3596_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/CM9.0000000000003318","volume":"138","author":"L Wang","year":"2025","unstructured":"Wang L, et al. Gut microbiota and parkinson\u2019s disease. Chin Med J (Engl). 2025;138:289\u201397. https:\/\/doi.org\/10.1097\/CM9.0000000000003318.","journal-title":"Chin Med J (Engl)"},{"key":"3596_CR21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/s0140-6736(84)91816-6","volume":"1","author":"BJ Marshall","year":"1984","unstructured":"Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(84)91816-6.","journal-title":"Lancet"},{"key":"3596_CR22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.5694\/j.1326-5377.1965.tb72277.x","volume":"1","author":"RR Strang","year":"1965","unstructured":"Strang RR. The association of Gastro-Duodenal ulceration and parkinson\u2019s disease. Med J Aust. 1965;1:842\u20133. https:\/\/doi.org\/10.5694\/j.1326-5377.1965.tb72277.x.","journal-title":"Med J Aust"},{"key":"3596_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3988\/jcn.2017.13.2.181","volume":"13","author":"KR Mridula","year":"2017","unstructured":"Mridula KR, Borgohain R, Reddy C, Bandaru V, V., Suryaprabha T. Association of Helicobacter pylori with parkinson\u2019s disease. J Clin Neurol. 2017;13:181\u20136. https:\/\/doi.org\/10.3988\/jcn.2017.13.2.181.","journal-title":"J Clin Neurol"},{"key":"3596_CR24","doi-asserted-by":"publisher","first-page":"1412157","DOI":"10.3389\/fimmu.2024.1412157","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Causal associations between Helicobacter pylori infection and the risk and symptoms of parkinson\u2019s disease: a Mendelian randomization study. Front Immunol. 2024;15:1412157. https:\/\/doi.org\/10.3389\/fimmu.2024.1412157.","journal-title":"Front Immunol"},{"key":"3596_CR25","doi-asserted-by":"publisher","first-page":"e01549","DOI":"10.1002\/brb3.1549","volume":"10","author":"H Wang","year":"2020","unstructured":"Wang H, et al. Bacterial, viral, and fungal infection-related risk of parkinson\u2019s disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10:e01549. https:\/\/doi.org\/10.1002\/brb3.1549.","journal-title":"Brain Behav"},{"key":"3596_CR26","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","volume":"325","author":"J Parsonnet","year":"1991","unstructured":"Parsonnet J, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127\u201331. https:\/\/doi.org\/10.1056\/NEJM199110173251603.","journal-title":"N Engl J Med"},{"key":"3596_CR27","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/s0016-5085(97)70155-0","volume":"112","author":"A Lee","year":"1997","unstructured":"Lee A, et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 1997;112:1386\u201397. https:\/\/doi.org\/10.1016\/s0016-5085(97)70155-0.","journal-title":"Gastroenterology"},{"key":"3596_CR28","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1128\/IAI.72.8.4668-4679.2004","volume":"72","author":"LJ Thompson","year":"2004","unstructured":"Thompson LJ, et al. Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL\/6 and BALB\/c mice. Infect Immun. 2004;72:4668\u201379. https:\/\/doi.org\/10.1128\/IAI.72.8.4668-4679.2004.","journal-title":"Infect Immun"},{"key":"3596_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1046\/j.1365-2036.1997.00234.x","volume":"11","author":"MR Cottrill","year":"1997","unstructured":"Cottrill MR, et al. Two omeprazole-based Helicobacter pylori eradication regimens for the treatment of duodenal ulcer disease in general practice. Aliment Pharmacol Ther. 1997;11:919\u201327. https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00234.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"3596_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-116-9-705","volume":"116","author":"DY Graham","year":"1992","unstructured":"Graham DY, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992;116:705\u20138. https:\/\/doi.org\/10.7326\/0003-4819-116-9-705.","journal-title":"Ann Intern Med"},{"key":"3596_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer P. The alpha-Synuclein origin and connectome model (SOC model) of parkinson\u2019s disease: explaining motor Asymmetry, Non-Motor Phenotypes, and cognitive decline. J Parkinson\u2019s Disease. 2021;11:455\u201374. https:\/\/doi.org\/10.3233\/JPD-202481.","journal-title":"J Parkinson\u2019s Disease"},{"key":"3596_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/JPD-181327","volume":"8","author":"DJ McGee","year":"2018","unstructured":"McGee DJ, Lu XH, Disbrow EA. Stomaching the possibility of a pathogenic role for Helicobacter pylori in parkinson\u2019s disease. J Parkinson\u2019s Disease. 2018;8:367\u201374. https:\/\/doi.org\/10.3233\/JPD-181327.","journal-title":"J Parkinson\u2019s Disease"},{"key":"3596_CR33","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1462-5822.2010.01551.x","volume":"13","author":"X Sewald","year":"2011","unstructured":"Sewald X, Jimenez-Soto L, Haas R. PKC-dependent endocytosis of the Helicobacter pylori vacuolating cytotoxin in primary T lymphocytes. Cell Microbiol. 2011;13:482\u201396. https:\/\/doi.org\/10.1111\/j.1462-5822.2010.01551.x.","journal-title":"Cell Microbiol"},{"key":"3596_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994;180:147\u201350. https:\/\/doi.org\/10.1016\/0304-3940(94)90508-8.","journal-title":"Neurosci Lett"},{"key":"3596_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, et al. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of alzheimer\u2019s and de Novo parkinson\u2019s disease patients. Neurosci Lett. 1995;202:17\u201320. https:\/\/doi.org\/10.1016\/0304-3940(95)12192-7.","journal-title":"Neurosci Lett"},{"key":"3596_CR36","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount MP, et al. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci. 2007;27:3328\u201337. https:\/\/doi.org\/10.1523\/JNEUROSCI.5321-06.2007.","journal-title":"J Neurosci"},{"key":"3596_CR37","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1038\/s41598-024-58407-x","volume":"14","author":"XT Yang","year":"2024","unstructured":"Yang XT, et al. Differential cytokine expression in gastric tissues highlights Helicobacter pylori\u2019s role in gastritis. Sci Rep. 2024;14:7683. https:\/\/doi.org\/10.1038\/s41598-024-58407-x.","journal-title":"Sci Rep"},{"key":"3596_CR38","doi-asserted-by":"crossref","unstructured":"Mariangela Massaro Cenere, Marta Tiberi, Emanuela Paldino, Sebastian Luca D'Addario, Mauro Federici, Cecilia Giacomet, et al. Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson's disease overexpressing human alpha synuclein. NPJ Parkinsons Dis. 2024;10(1):213.","DOI":"10.1038\/s41531-024-00824-w"},{"key":"3596_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0008-8749(88)90109-8","volume":"111","author":"JP Siegel","year":"1988","unstructured":"Siegel JP. Effects of interferon-gamma on the activation of human T lymphocytes. Cell Immunol. 1988;111:461\u201372. https:\/\/doi.org\/10.1016\/0008-8749(88)90109-8.","journal-title":"Cell Immunol"},{"key":"3596_CR40","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/brain\/awaa269","volume":"143","author":"J Galiano-Landeira","year":"2020","unstructured":"Galiano-Landeira J, Torra A, Vila M, Bove J. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of parkinson\u2019s disease. Brain. 2020;143:3717\u201333. https:\/\/doi.org\/10.1093\/brain\/awaa269.","journal-title":"Brain"},{"key":"3596_CR41","doi-asserted-by":"publisher","unstructured":"Zhu B et al. Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease brains. Science translational medicine. 2024;16:eabo1997. https:\/\/doi.org\/10.1126\/scitranslmed.abo1997.","DOI":"10.1126\/scitranslmed.abo1997"},{"key":"3596_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67","author":"S Theodore","year":"2008","unstructured":"Theodore S, Cao S, McLean PJ, Standaert DG. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2008;67:1149\u201358. https:\/\/doi.org\/10.1097\/NEN.0b013e31818e5e99.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3596_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, et al. Infiltration of CD4\u2009+\u2009lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Investig. 2009;119:182\u201392. https:\/\/doi.org\/10.1172\/JCI36470.","journal-title":"J Clin Investig"},{"key":"3596_CR44","doi-asserted-by":"publisher","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","volume":"5","author":"V Sanchez-Guajardo","year":"2010","unstructured":"Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of parkinson\u2019s disease. PLoS ONE. 2010;5:e8784. https:\/\/doi.org\/10.1371\/journal.pone.0008784.","journal-title":"PLoS ONE"},{"key":"3596_CR45","doi-asserted-by":"publisher","unstructured":"Harms AS, et al. Alpha-synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Acta Neuropathol Commun. 2017;5. https:\/\/doi.org\/10.1186\/s40478-017-0494-9.","DOI":"10.1186\/s40478-017-0494-9"},{"key":"3596_CR46","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","volume":"22","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, et al. Spread of alpha-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nat Neurosci. 2019;22:1248\u201357. https:\/\/doi.org\/10.1038\/s41593-019-0457-5.","journal-title":"Nat Neurosci"},{"key":"3596_CR47","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338:949\u201353. https:\/\/doi.org\/10.1126\/science.1227157.","journal-title":"Science"},{"key":"3596_CR48","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.22.619411","author":"N Vatsa","year":"2024","unstructured":"Vatsa N, et al. Network analysis of alpha-synuclein pathology progression reveals p21-activated kinases as regulators of vulnerability. BioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.10.22.619411.","journal-title":"BioRxiv"},{"key":"3596_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41531-024-00824-w","volume":"10","author":"M Massaro Cenere","year":"2024","unstructured":"Massaro Cenere M, et al. Systemic inflammation accelerates neurodegeneration in a rat model of parkinson\u2019s disease overexpressing human alpha synuclein. NPJ Parkinson\u2019s Disease. 2024;10:213. https:\/\/doi.org\/10.1038\/s41531-024-00824-w.","journal-title":"NPJ Parkinson\u2019s Disease"},{"key":"3596_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.17879\/freeneuropathology-2021-3326","volume":"2","author":"S Grathwohl","year":"2021","unstructured":"Grathwohl S, et al. Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology. Free Neuropathol. 2021;2:13. https:\/\/doi.org\/10.17879\/freeneuropathology-2021-3326.","journal-title":"Free Neuropathol"},{"key":"3596_CR51","doi-asserted-by":"publisher","first-page":"103931","DOI":"10.1016\/j.mcn.2024.103931","volume":"129","author":"AS Laursen","year":"2024","unstructured":"Laursen AS, et al. Systemic inflammation activates coagulation and immune cell infiltration pathways in brains with propagating alpha-synuclein fibril aggregates. Mol Cell Neurosci. 2024;129:103931. https:\/\/doi.org\/10.1016\/j.mcn.2024.103931.","journal-title":"Mol Cell Neurosci"},{"key":"3596_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12017-019-08539-5","volume":"21","author":"Y Kishimoto","year":"2019","unstructured":"Kishimoto Y, Zhu W, Hosoda W, Sen JM, Mattson MP. Chronic mild gut inflammation accelerates brain neuropathology and motor dysfunction in alpha-Synuclein mutant mice. Neuromolecular Med. 2019;21:239\u201349. https:\/\/doi.org\/10.1007\/s12017-019-08539-5.","journal-title":"Neuromolecular Med"},{"key":"3596_CR53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55:453\u201362. https:\/\/doi.org\/10.1002\/glia.20467.","journal-title":"Glia"},{"key":"3596_CR54","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/glia.22479","volume":"61","author":"L Qin","year":"2013","unstructured":"Qin L, Liu Y, Hong JS, Crews FT. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Glia. 2013;61:855\u201368. https:\/\/doi.org\/10.1002\/glia.22479.","journal-title":"Glia"},{"key":"3596_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41401-023-01147-x","volume":"45","author":"XZ Ma","year":"2024","unstructured":"Ma XZ, et al. Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia Nigra of parkinsonian mice. Acta Pharmacol Sin. 2024;45:52\u201365. https:\/\/doi.org\/10.1038\/s41401-023-01147-x.","journal-title":"Acta Pharmacol Sin"},{"key":"3596_CR56","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4049\/jimmunol.179.3.1413","volume":"179","author":"JJ Oppenheim","year":"2007","unstructured":"Oppenheim JJ. IL-2: more than a T cell growth factor. J Immunol. 2007;179:1413\u20134. https:\/\/doi.org\/10.4049\/jimmunol.179.3.1413.","journal-title":"J Immunol"},{"key":"3596_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41\u201353. https:\/\/doi.org\/10.1038\/nrn1824.","journal-title":"Nat Rev Neurosci"},{"key":"3596_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","volume":"10","author":"C Wang","year":"2021","unstructured":"Wang C, Yang T, Liang M, Xie J, Song N. Astrocyte dysfunction in parkinson\u2019s disease: from the perspectives of transmitted alpha-synuclein and genetic modulation. Translational Neurodegeneration. 2021;10:39. https:\/\/doi.org\/10.1186\/s40035-021-00265-y.","journal-title":"Translational Neurodegeneration"},{"key":"3596_CR59","doi-asserted-by":"publisher","unstructured":"Palacios E, et al. Helicobacter pylori outer membrane vesicles induce astrocyte reactivity through nuclear factor-kappaappa B activation and cause neuronal damage in vivo in a murine model. J Neuroinflamm. 2023;20. https:\/\/doi.org\/10.1186\/s12974-023-02728-7.","DOI":"10.1186\/s12974-023-02728-7"},{"key":"3596_CR60","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12974-020-01911-4","volume":"17","author":"MS Subbarayan","year":"2020","unstructured":"Subbarayan MS, Hudson C, Moss LD, Nash KR, Bickford PC. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an alpha-synuclein rat model of parkinson\u2019s disease. J Neuroinflamm. 2020;17:242. https:\/\/doi.org\/10.1186\/s12974-020-01911-4.","journal-title":"J Neuroinflamm"},{"key":"3596_CR61","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebrian","year":"2014","unstructured":"Cebrian C, et al. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun. 2014;5:3633. https:\/\/doi.org\/10.1038\/ncomms4633.","journal-title":"Nat Commun"},{"key":"3596_CR62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, et al. T cells from patients with parkinson\u2019s disease recognize alpha-synuclein peptides. Nature. 2017;546:656\u201361. https:\/\/doi.org\/10.1038\/nature22815.","journal-title":"Nature"},{"key":"3596_CR63","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1093\/brain\/awx177","volume":"140","author":"LA Hoffman","year":"2017","unstructured":"Hoffman LA, Vilensky JA. Encephalitis lethargica: 100 years after the epidemic. Brain. 2017;140:2246\u201351. https:\/\/doi.org\/10.1093\/brain\/awx177.","journal-title":"Brain"},{"key":"3596_CR64","doi-asserted-by":"publisher","first-page":"fcae347","DOI":"10.1093\/braincomms\/fcae347","volume":"6","author":"JP Rogers","year":"2024","unstructured":"Rogers JP, et al. Encephalitis lethargica: clinical features and aetiology. Brain Commun. 2024;6:fcae347. https:\/\/doi.org\/10.1093\/braincomms\/fcae347.","journal-title":"Brain Commun"},{"key":"3596_CR65","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s007020050086","volume":"105","author":"J Casals","year":"1998","unstructured":"Casals J, Elizan TS, Yahr MD. Postencephalitic parkinsonism\u2013a review. J Neural Transm (Vienna). 1998;105:645\u201376. https:\/\/doi.org\/10.1007\/s007020050086.","journal-title":"J Neural Transm (Vienna)"},{"key":"3596_CR66","doi-asserted-by":"publisher","unstructured":"Polverino P, De Santis T, Perdixi E, Chio A, Albanese A. Case report: atypical parkinsonism following SARS-CoV-2 infection. Front Neurol. 2023;14.\u00a0https:\/\/doi.org\/10.3389\/fneur.2023.1208213.","DOI":"10.3389\/fneur.2023.1208213"},{"key":"3596_CR67","doi-asserted-by":"publisher","unstructured":"Cavallieri F, et al. COVID-19 and parkinsonism: a critical appraisal. Biomolecules. 2022;12. https:\/\/doi.org\/10.3390\/biom12070970.","DOI":"10.3390\/biom12070970"},{"key":"3596_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/ncn3.12679","volume":"11","author":"W Mitarnun","year":"2023","unstructured":"Mitarnun W, Apiwattanakul M, Thodthasri T, Tantisungvarakoon P, Pangwong W. Steroid administration for post-COVID-19 parkinsonism: A case report. Neurol Clin Neurosci. 2023;11:49\u201351. https:\/\/doi.org\/10.1111\/ncn3.12679.","journal-title":"Neurol Clin Neurosci"},{"key":"3596_CR69","doi-asserted-by":"publisher","unstructured":"Rai SN, et al. Exploring the paradox of COVID-19 in neurological complications with emphasis on parkinson\u2019s and alzheimer\u2019s disease. Oxidative Med Cell Longev. 2022;2022:3012778. https:\/\/doi.org\/10.1155\/2022\/3012778.","DOI":"10.1155\/2022\/3012778"},{"key":"3596_CR70","doi-asserted-by":"publisher","first-page":"106066","DOI":"10.1016\/j.parkreldis.2024.106066","volume":"123","author":"P Polverino","year":"2024","unstructured":"Polverino P, Cocco A, Albanese A. Post-COVID parkinsonism: A scoping review. Parkinsonism Relat Disord. 2024;123:106066. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106066.","journal-title":"Parkinsonism Relat Disord"},{"key":"3596_CR71","doi-asserted-by":"publisher","unstructured":"Jellinger KA. Concomitant pathologies and their impact on Parkinson disease: a narrative overview of current evidence. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26072942.","DOI":"10.3390\/ijms26072942"},{"key":"3596_CR72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2.","journal-title":"Nat Rev Microbiol"},{"key":"3596_CR73","doi-asserted-by":"publisher","first-page":"100290","DOI":"10.1016\/j.bbih.2021.100290","volume":"16","author":"P Najt","year":"2021","unstructured":"Najt P, Richards HL, Fortune DG. Brain imaging in patients with COVID-19: A systematic review. Brain Behav Immun Health. 2021;16:100290. https:\/\/doi.org\/10.1016\/j.bbih.2021.100290.","journal-title":"Brain Behav Immun Health"},{"key":"3596_CR74","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","volume":"24","author":"J Meinhardt","year":"2021","unstructured":"Meinhardt J, et al. Olfactory transmucosal SARS-CoV-2 invasion as a Port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168\u201375. https:\/\/doi.org\/10.1038\/s41593-020-00758-5.","journal-title":"Nat Neurosci"},{"key":"3596_CR75","doi-asserted-by":"publisher","first-page":"e13013","DOI":"10.1111\/bpa.13013","volume":"31","author":"A Maiese","year":"2021","unstructured":"Maiese A, et al. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathol. 2021;31:e13013. https:\/\/doi.org\/10.1111\/bpa.13013.","journal-title":"Brain Pathol"},{"key":"3596_CR76","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41593-025-01871-z","volume":"28","author":"R Fekete","year":"2025","unstructured":"Fekete R, et al. Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19. Nat Neurosci. 2025;28:558\u201376. https:\/\/doi.org\/10.1038\/s41593-025-01871-z.","journal-title":"Nat Neurosci"},{"key":"3596_CR77","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1586\/17474124.2015.1095089","volume":"9","author":"M Miftahussurur","year":"2015","unstructured":"Miftahussurur M, Yamaoka Y. Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2015;9:1535\u201347. https:\/\/doi.org\/10.1586\/17474124.2015.1095089.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3596_CR78","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1053\/gast.2002.37043","volume":"123","author":"IR Hwang","year":"2002","unstructured":"Hwang IR, et al. Effect of Interleukin 1 polymorphisms on gastric mucosal Interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123:1793\u2013803. https:\/\/doi.org\/10.1053\/gast.2002.37043.","journal-title":"Gastroenterology"},{"key":"3596_CR79","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1053\/gast.2002.34156","volume":"123","author":"T Furuta","year":"2002","unstructured":"Furuta T, et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology. 2002;123:92\u2013105. https:\/\/doi.org\/10.1053\/gast.2002.34156.","journal-title":"Gastroenterology"},{"key":"3596_CR80","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/humu.20299","volume":"27","author":"M Chakravorty","year":"2006","unstructured":"Chakravorty M, et al. Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat. 2006;27:411\u20139. https:\/\/doi.org\/10.1002\/humu.20299.","journal-title":"Hum Mutat"},{"key":"3596_CR81","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0002-9343(01)01036-1","volume":"112","author":"T Furuta","year":"2002","unstructured":"Furuta T, Shirai N, Takashima M, Xiao F, Sugimura H. Effect of genotypic differences in interleukin-1 beta on gastric acid secretion in Japanese patients infected with Helicobacter pylori. Am J Med. 2002;112:141\u20133. https:\/\/doi.org\/10.1016\/s0002-9343(01)01036-1.","journal-title":"Am J Med"},{"key":"3596_CR82","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3233\/JPD-191877","volume":"10","author":"CU von Linstow","year":"2020","unstructured":"von Linstow CU, DeLano-Taylor M, Kordower JH, Brundin P. Does developmental variability in the number of midbrain dopamine neurons affect individual risk for sporadic parkinson\u2019s disease? J Parkinson\u2019s Disease. 2020;10:405\u201311. https:\/\/doi.org\/10.3233\/JPD-191877.","journal-title":"J Parkinson\u2019s Disease"},{"key":"3596_CR83","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3233\/JPD-240195","volume":"14","author":"G Mercado","year":"2024","unstructured":"Mercado G, Kaeufer C, Richter F, Peelaerts W. Infections in the etiology of parkinson\u2019s disease and synucleinopathies: A renewed Perspective, mechanistic Insights, and therapeutic implications. J Parkinson\u2019s Disease. 2024;14:1301\u201329. https:\/\/doi.org\/10.3233\/JPD-240195.","journal-title":"J Parkinson\u2019s Disease"},{"key":"3596_CR84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JPD-202279","volume":"11","author":"RJ Smeyne","year":"2021","unstructured":"Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Infection and risk of parkinson\u2019s disease. J Parkinson\u2019s Disease. 2021;11:31\u201343. https:\/\/doi.org\/10.3233\/JPD-202279.","journal-title":"J Parkinson\u2019s Disease"},{"key":"3596_CR85","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, et al. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657\u201373. https:\/\/doi.org\/10.1038\/s41577-022-00684-6.","journal-title":"Nat Rev Immunol"},{"key":"3596_CR86","doi-asserted-by":"publisher","first-page":"e0251042","DOI":"10.1371\/journal.pone.0251042","volume":"16","author":"P Lolekha","year":"2021","unstructured":"Lolekha P, Sriphanom T, Vilaichone RK. Helicobacter pylori eradication improves motor fluctuations in advanced parkinson\u2019s disease patients: A prospective cohort study (HP-PD trial). PLoS ONE. 2021;16:e0251042. https:\/\/doi.org\/10.1371\/journal.pone.0251042.","journal-title":"PLoS ONE"},{"key":"3596_CR87","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3988\/jcn.2016.12.2.147","volume":"12","author":"G Camci","year":"2016","unstructured":"Camci G, Oguz S. Association between parkinson\u2019s disease and Helicobacter pylori. J Clin Neurol. 2016;12:147\u201350. https:\/\/doi.org\/10.3988\/jcn.2016.12.2.147.","journal-title":"J Clin Neurol"},{"key":"3596_CR88","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/mds.22190","volume":"23","author":"WY Lee","year":"2008","unstructured":"Lee WY, Yoon WT, Shin HY, Jeon SH, Rhee PL. Helicobacter pylori infection and motor fluctuations in patients with parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc. 2008;23:1696\u2013700. https:\/\/doi.org\/10.1002\/mds.22190.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"3596_CR89","doi-asserted-by":"publisher","unstructured":"Di Lazzaro G, et al. Differential profiles of serum cytokines in Parkinson\u2019s disease according to disease duration. Neurobiol Dis. 2024;190. https:\/\/doi.org\/10.1016\/j.nbd.2023.106371.","DOI":"10.1016\/j.nbd.2023.106371"},{"key":"3596_CR90","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VM. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to lewy body and lewy neurite-like aggregates. Nat Protoc. 2014;9:2135\u201346. https:\/\/doi.org\/10.1038\/nprot.2014.143.","journal-title":"Nat Protoc"},{"key":"3596_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, et al. Exogenous alpha-synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. 2011;72:57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033.","journal-title":"Neuron"},{"key":"3596_CR92","doi-asserted-by":"publisher","first-page":"e3000231","DOI":"10.1371\/journal.pbio.3000231","volume":"17","author":"C Fung","year":"2019","unstructured":"Fung C, et al. High-resolution mapping reveals that microniches in the gastric glands control Helicobacter pylori colonization of the stomach. PLoS Biol. 2019;17:e3000231. https:\/\/doi.org\/10.1371\/journal.pbio.3000231.","journal-title":"PLoS Biol"},{"key":"3596_CR93","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5.","journal-title":"Sci Rep"},{"key":"3596_CR94","doi-asserted-by":"publisher","unstructured":"Yates SC, et al. QUINT: workflow for quantification and Spatial analysis of features in histological images from rodent brain. Front Neuroinformatics. 2019;13:75.https:\/\/doi.org\/10.3389\/fninf.2019.00075.","DOI":"10.3389\/fninf.2019.00075"},{"key":"3596_CR95","doi-asserted-by":"publisher","unstructured":"Wang Q et al. The allen mouse brain common coordinate framework: a 3D reference atlas. Cell.2020;181:936\u2013953 e920. https:\/\/doi.org\/10.1016\/j.cell.2020.04.007.","DOI":"10.1016\/j.cell.2020.04.007"},{"key":"3596_CR96","doi-asserted-by":"publisher","first-page":"e0216796","DOI":"10.1371\/journal.pone.0216796","volume":"14","author":"MA Puchades","year":"2019","unstructured":"Puchades MA, Csucs G, Ledergerber D, Leergaard TB, Bjaalie JG. Spatial registration of serial microscopic brain images to three-dimensional reference atlases with the quicknii tool. PLoS ONE. 2019;14:e0216796. https:\/\/doi.org\/10.1371\/journal.pone.0216796.","journal-title":"PLoS ONE"},{"key":"3596_CR97","doi-asserted-by":"publisher","unstructured":"Groeneboom NE, Yates SC, Puchades MA, Bjaalie JG, Nutil. A pre- and post-processing toolbox for histological rodent brain section images. Front Neuroinformatics. 2020;14. https:\/\/doi.org\/10.3389\/fninf.2020.00037.","DOI":"10.3389\/fninf.2020.00037"},{"key":"3596_CR98","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/00031305.2018.1537893","volume":"73","author":"JD Blume","year":"2019","unstructured":"Blume JD, Greevy RA, Welty VF, Smith JR, Dupont WD. An introduction to Second-Generation p-Values. Am Stat. 2019;73:157\u201367. https:\/\/doi.org\/10.1080\/00031305.2018.1537893.","journal-title":"Am Stat"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03596-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03596-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03596-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T03:02:26Z","timestamp":1766458946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-025-03596-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3596"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03596-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}